USA |NASDAQ |USD
Revenues were $384.54K, up by 72.74% from previous year's revenue.
The company reported a net income of $-3.93M.
Lexaria Bioscience reported a free cash flow of $-2.66M for its fiscal year, compared to $-3.77M a year ago.
The company ended the fiscal year with $36.04K in total debt. lala